Molecular Testing in Thyroid Cancer

0 Views
administrator
administrator
07/01/23

Panelists R. Michael Tuttle, MD; Eric J. Sherman, MD; Marcia S. Brose, MD, PhD; Naifa Busaidy, MD, FAPC, FACE; and Frank Worden, MD, discuss the present day use of molecular testing for thyroid cancer, which, for now, is largely prognostic but not predictive.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next